Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$17.05 +1.53%

+$0.24 today

Market cap
$1.19B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.35M

Average 2.43M

TNDM Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Tandem Diabetes Care, Inc.NASDAQ: TNDM

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 68.4M shares rose 3.0% year over year, in line with the +3.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +1.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +3.0% toward the trailing-twelve-month pace of +3.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
68.4M+0.6% QoQ
Last fiscal yearDec 2025
67.29M+2.8% YoY
LTMMar 2026
67.78M+3.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.0%——
1 year+2.8%——
3-year CAGR+1.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
67.29M USD
Year-over-year change
+2.8%
4-year CAGR
+1.1%

Weighted Avg Shares (Diluted) vs competitors

How TNDM compares with its peers on the latest reported figures

  • TNDM's LTM Mar 2026 weighted avg shares (diluted) of 67.78M shares is the 5th highest of the 8 companies compared; the peer median is 70.23M shares.
  • Its year-over-year change of +3.0% is the 5th highest of 7, against a peer median of +6.8%.
  • Over three fiscal years its annual growth of +1.6% compares with a peer median of +6.9%.
TNDM Competitors Peer median
Weighted Avg Shares (Diluted) for TNDM and competitors
Company Period LTM YoY 3-year CAGR
DXCMDexCom, Inc.LTM Jun 2026397.93M -2.5%-1.7%
MNKDMannKind CorporationLTM Mar 2026311.38M +6.5%+6.9%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026207.48M —-3.0%
PODDInsulet CorporationLTM Jun 202670.23M -4.0%+0.9%
TNDMTandem Diabetes Care, Inc.LTM Mar 202667.78M +3.0%+1.6%
GUTSFractyl Health, Inc. Common StockLTM Mar 202666.33M +37.1%+16.8%
BBNXBeta Bionics, Inc.LTM Mar 202643M +7.0%+100.9%
SENSSenseonics Holdings, Inc.LTM Mar 202640.57M +23.7%+10.5%
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding TNDM) 70.23M+6.8%+6.9%

Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue702.8M801.22M747.72M940.2M1.01B
Cost of Revenue326.58M388.23M380.03M450.63M483.89M
Gross Profit376.22M412.99M367.69M489.57M530.85M
Gross Margin53.5%51.5%49.2%52.1%52.3%
Research & Development92.05M170.15M248.42M198.88M174.84M
Selling, General & Admin261.51M335.68M352.5M389.82M434.13M
Operating Expenses353.56M505.83M600.92M588.7M608.97M
Depreciation & Amortization13.85M14.33M15.72M158K17.67M
EBITDA34.06M(74.21M)(196.46M)(99.13M)(174.7M)
EBITDA Margin4.8%-9.3%-26.3%-10.5%-17.2%
Operating Income22.65M(92.85M)(233.23M)(99.13M)(78.12M)
Operating Margin3.2%-11.6%-31.2%-10.5%-7.7%
Interest Income674K6.06M22.86M17.99M9.09M
Interest Expense6.04M6.21M9.88M7.42M7.91M
Other Income / Expenses(6.75M)(4K)12.98M7.26M(122.15M)
Income Before Tax15.9M(92.85M)(220.25M)(91.87M)(200.27M)
Pre-Tax Margin2.3%-11.6%-29.5%-9.8%-19.7%
Income Tax Expense335K1.74M2.36M4.16M4.44M
Net Income15.57M(94.59M)(222.61M)(96.03M)(204.71M)
Net Margin2.2%-11.8%-29.8%-10.2%-20.2%
EPS (Basic)0.25(1.47)(3.43)(1.47)(3.04)
EPS (Diluted)0.24(1.47)(3.43)(1.47)(3.04)
Weighted Avg Shares63M64.15M64.9M65.45M67.29M
Weighted Avg Shares (Diluted)64.35M64.15M64.97M65.45M67.29M

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.